Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 5
2011 1
2012 4
2013 3
2014 1
2015 4
2016 3
2017 1
2018 2
2020 2
2021 2
2022 7
2023 3
2024 3
2025 11
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Spontaneous and Drug-Induced Amyloid-Related Imaging Abnormalities: Overlaps, Divergences, and Clinical Implications Across a Continuum Between Alzheimer's Disease and Cerebral Amyloid Angiopathy.
Zedde M, Losa M, Grisafi E, Lucia DD, Gandoglia I, Del Sette M, Pardini M, Roccatagliata L, Pascarella R, Piazza F. Zedde M, et al. Among authors: piazza f. Biomolecules. 2026 Jan 5;16(1):89. doi: 10.3390/biom16010089. Biomolecules. 2026. PMID: 41594629 Free PMC article. Review.
Microbiota-gut-brain axis dysregulation in Alzheimer's disease and its modulation through probiotic supplementation.
Marizzoni M, Mombelli E, Alboni S, Rosa M, Moretti DV, Mirabelli P, Coppola L, Luongo D, Salamone D, Saleri S, Piazza F, Begni V, Salvatore M, Frisoni GB, Cattaneo A. Marizzoni M, et al. Among authors: piazza f. Brain Behav Immun. 2026 Jan;131:106138. doi: 10.1016/j.bbi.2025.106138. Epub 2025 Oct 13. Brain Behav Immun. 2026. PMID: 41093142 Free article.
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes.
Losa M, Ramusino MC, Cama I, Gualco L, Gandoglia I, Massa F, Donniaquio A, Mortola P, Argenti L, Lombardo L, Kreshpa W, Pelagotti V, Bozzo G, Orso B, Mattioli P, Arnaldi D, Cirone A, Ali S MSc, Hamedani M, Pulze M, Plantone D, Lorenzini L, Falcitano L, Mazzacane F, Perini G, Costa A, Piana M, Castellan L, Uccelli A, Schenone A, Kozberg M, Piazza F, Del Sette M, Garbarino S, Roccatagliata L, Farina LM, Pardini M. Losa M, et al. Among authors: piazza f. J Am Heart Assoc. 2025 Oct 21;14(20):e044784. doi: 10.1161/JAHA.125.044784. Epub 2025 Oct 14. J Am Heart Assoc. 2025. PMID: 41085178 Free PMC article.
Advancing dementia care: a review of Italy's public health response within the WHO Global Action Plan and European strategies.
Ancidoni A, Salemme S, Marconi D, Bellomo G, Pani SM, Locuratolo N, Lacorte E, Lombardo FL, Bacigalupo I, Fabrizi E, Canevelli M, Sciancalepore F, Lorenzini P, Palazzesi I, Paggetti A, Della Gatta F, Piscopo P, Salvi E, Zambri F, Di Nolfi A, Palermo V, Sciattella P, Bini C, Mennini FS, Bianchi CBNA, Landoni F, Giannini MA, Di Fiandra T, Vanacore N; National Committee on Dementia of the National Dementia Plan; FONDEM Study Group; National Guideline Working Group. Ancidoni A, et al. BMJ Public Health. 2025 Aug 17;3(2):e002250. doi: 10.1136/bmjph-2024-002250. eCollection 2025. BMJ Public Health. 2025. PMID: 40832647 Free PMC article.
Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA Association and the World Stroke Organization.
Cordonnier C, Klijn C, Smith EE, Al-Shahi Salman R, Chwalisz BK, van Etten E, Muir RT, Piazza F, Schreiber S, Schreuder FH, Selim M, Shoamanesh A, Viswanathan A, Wermer M, Zandi M, Charidimou A, Greenberg SM, Werring D. Cordonnier C, et al. Among authors: piazza f. Int J Stroke. 2025 Oct;20(8):949-967. doi: 10.1177/17474930251365861. Epub 2025 Jul 28. Int J Stroke. 2025. PMID: 40721902 Free article.
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.
Jessen F, Arbizu J, Boada M, Balasa M, Bennys K, Boban M, Bürger K, Chincarini A, Cagnin A, De Deyn PP, Düzel E, Engelborghs S, Ewers M, Exalto LG, van der Flier WM, Fortea J, Frederiksen KS, Frisoni GB, Frölich L, Garza-Martinez AJ, Grimmer T, Hanseeuw B, Hort J, Ivanoiu A, Kehoe PG, Kennelly SP, Kern S, Klöppel S, Krajčovičová L, Kramberger MG, McGuinness B, Mecocci P, Oberstein TJ, Ousset PJ, Paquet C, Perneczky R, Piazza F, Plantone D, Rainero I, Sacco G, Salmon E, Santana I, Scarmeas N, Schneider A, Schott JM, Solje E, Stefanova E, Stögmann E, Strauss M, Sutovsky S, Waldemar G, Winblad B. Jessen F, et al. Among authors: piazza f. J Prev Alzheimers Dis. 2025 Sep;12(8):100259. doi: 10.1016/j.tjpad.2025.100259. Epub 2025 Jul 9. J Prev Alzheimers Dis. 2025. PMID: 40640062 Free PMC article. No abstract available.
52 results